Navigation Links
PeriGen Knowledge Summit to Address Issues in Maternal Healthcare
Date:4/16/2010

Despite recent reports that show improved maternal healthcare worldwide, Amnesty International and The Lancet have found the standard of care dropping in the United States. PeriGen’s Knowledge Summit’s speakers will discuss why, and what can be done to correct this problem.

Washingtion, DC (Vocus) April 16, 2010 -- A new study in Lancet claims that maternal mortality rates around the world are going down. That should be good news in the debate over U.S. healthcare costs, except that the U.S. has an appalling record for maternal and infant mortality.

Amnesty International issued its own condemnation of U.S. maternity care, citing an infant mortality rate far above countries with fewer doctors, outdated technologies and primitive pre-natal care.

How can that be?
Come hear for yourself at the maternal-fetal medicine knowledge summit next Thursday, April 22 and Friday, April 23 at the Fairfax Embassy Row, 2100 Massachusetts Ave., N.W. The agenda for these meetings will address the maternal fetal medicine state of crisis: global and national maternity care; trends in healthcare information technology; and healthcare reform.

Did You Know?

 
  • Amnesty International’s March 2010 “Maternal Health Care Crisis in the USA” reports 34,000 American women have near-death experiences each year as they try to give birth.
  • The United States ranks 46th in infant mortality rate worldwide that’s below Cuba and just ahead of Croatia.
  • 30 percent of all births have incidents of difficulties that can lead to trauma
  • Studies show that 50 percent of avoidable medical errors are due to errors in cognition, and errors of communication.

WHO:   Nan Strauss, J.D. of Amnesty International will address global maternal-fetal morbidity and mortality rates, as well as clinical issues and trends and how the U.S. can improve its position as one of the lowest-ranked industrialized nations in terms of maternity care.
Dr. Peter Pronovost, an intensive care specialist and professor at Johns Hopkins Hospital and Johns Hopkins University School of Medicine. Dr. Pronovost is an internationally acclaimed leader in patient safety, whose ‘’checklist” concept dramatically reduced the rate of hospital-acquired infections after surgery.
Dr. Dan O’Keefe, Maternal-Fetal Medicine specialist, Chief Medical Officer for PeriGen

WHEN:   Thursday, April 22 and Friday, April 23, 2010

WHERE:   Fairfax Embassy Row
2100 Massachusetts Ave., N.W.
Washington, DC 20008

SPONSOR:   PeriGen

Anyone interested in attending should contact:

Brian Hegarty
Media Specialist

karma
230 south broad street, suite 1500
philadelphia, pennsylvania 19102

e brian(at)karmaverse(dot)com
p 215.790.7847 f 215.790.9751

###

Read the full story at http://www.prweb.com/releases/perigen/knowledge-summit/prweb3888134.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved

Related medicine news :

1. BusinessProcessGuidance.com Survey Exposes a Knowledge Worker Productivity Gap
2. Compass Knowledge Group and University of Illinois at Chicago to Co-Present at UCEA National Conference April 2010
3. New UCSF Global Health Initiative Will Help Bridge Gap Between Knowledge, Action
4. New global health initiative will help bridge gap between knowledge, action
5. Adritech Software Releases Website Realizer, a Website Builder to Create Websites without Any Programming Knowledge
6. Beware the Gentle Man With Unique Knowledge: The Passion and Skill of a Rising Star
7. American Heart Association Rapid Access Journal Report: Study Finds Racial Gaps Continue in Heart Disease Awareness, Low Knowledge of Heart Attack Warning Signs Among Women
8. Renowned Duke researcher wins Frontiers of Knowledge Award
9. Lefkowitz, BBVA Foundation Frontiers of Knowledge Award in Biomedicine
10. Firsthand Knowledge of E85 Earns Waconia Man a Free Trip to Soldier Field to See Monday Night Vikings-Bears Game
11. Projects In Knowledge(R) Is Brightening the Holidays for Many in Need
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2017)... ... February 26, 2017 , ... IndustryArchive.Org . is announcing ... B2B Marketing. B2B Sellers will now only pay for B.A.N.T. quality sales leads based ... of IndustryArchive.Org, said, “Given the new reality that B2B buyers are controlling the sales ...
(Date:2/25/2017)... ... February 25, 2017 , ... FCPX users now have ... from Pixel Film Studios. With ProSharpen Color users have total control over sharpening amount, ... their color range. With color spectrum tools users can visually see the color range ...
(Date:2/24/2017)... ... February 24, 2017 , ... An in-depth computational analysis of ... of Pittsburgh points to eight genes that may explain why susceptibility to one of ... results of a study published today in the journal npj Schizophrenia. , “There ...
(Date:2/24/2017)... ... February 24, 2017 , ... Healthcare Associates of ... Center at Craig Ranch building at 8080 State Highway 121, Suite 210, McKinney, Texas ... easy access to Highway 121. , As the practice has grown, the need for ...
(Date:2/24/2017)... ... 2017 , ... The International Association of Eating Disorders Professionals (iaedp) announces the ... body image mannequin art competition. Selected from 15 submissions from around the nation, the ... the 31st annual iaedp Symposium, March 22 – 26 in Las Vegas. , This ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... , Australie, le 24 février 2017 ITL Limited, ... santé diversifiée innovante, est ravie d,annoncer les excellents résultats ... la période précédente correspondante. Une présentation complète « Résultats et ... être consultée ici . Faits ... de 2,12 millions $ (Déc. 2015 : 1,04 million $ ; en hausse de ...
(Date:2/24/2017)... , Feb. 23, 2017 ... insights on the various drugs being developed ... covers all the drugs that are in ... Clinical). The pipeline focuses on novel pharmacologic ... antibodies, stem cell therapies, recombinant proteins and ...
(Date:2/24/2017)... Feb. 24, 2017  Xynomic Pharmaceuticals, Inc., an oncology ... it has acquired exclusive worldwide rights to develop, ... HDAC inhibitor targeting hematological and solid tumors. ... 1 and 2 clinical trials of Abexinostat in ... have already been completed, demonstrating that Abexinostat is ...
Breaking Medicine Technology: